Progress in immunotherapy rituximab.
MM El-Habbash, AM Alwindi - Saudi medical journal, 2007 - europepmc.org
Rituximab is an anti-CD20 chimeric monoclonal antibody that has shown substantial activity.
Since its discovery, rituximab has been used with great success in a variety of …
Since its discovery, rituximab has been used with great success in a variety of …
Male breast cancer in Tripoli, Libya.
MM El-Habbash, AA Alwindi - Saudi medical journal, 2009 - europepmc.org
Methods This non-randomized retrospective study includes male patients with breast cancer
confirmed by biopsy. A total of 1568 breast cancer patients were registered in the Oncology …
confirmed by biopsy. A total of 1568 breast cancer patients were registered in the Oncology …
Progress in immunotherapy Rituximab
EH Manal M, A Abukris M - 2007 - pesquisa.bvsalud.org
Rituximab is an anti-CD20 chimeric monoclonal antibody that has shown substantial activity.
Since its discovery, rituximab has been used with great success in a variety of …
Since its discovery, rituximab has been used with great success in a variety of …
[PDF][PDF] Survival of breast cancer in very young women< 35years treated in Tripoli/Libya
MM El-Habbash, AA Alwindi - Pan, 2013 - amaac.org
Study objective: To study survival of breast cancer in very young age women< 35 years over
the period between 2000-2005. To relate recurrence rate and survival to risk factors as …
the period between 2000-2005. To relate recurrence rate and survival to risk factors as …
[PDF][PDF] Rituximab in non-Hodgkin Lymphoma (NHL).
M Elhabbash, A Alwindi - Pan Arab Journal of Oncology, 2015 - amaac.org
… Manal Elhabbash MD1, Abukris Alwindi MD2 … Dotan E, Aggarwal C, Smith M. Impact of
Rituximab on the treatment of B-cell Non-Hodgkin's Lymphoma. A peer –reviewed journal …
Rituximab on the treatment of B-cell Non-Hodgkin's Lymphoma. A peer –reviewed journal …
Male breast cancer in Tripoli, Libya
EH Manal M, A Abukris A - 2009 - pesquisa.bvsalud.org
To study the epidemiology, characteristics, and survival of male breast cancer patients. This
non-randomized retrospective study includes male patients with breast cancer confirmed by …
non-randomized retrospective study includes male patients with breast cancer confirmed by …
[CITATION][C] Paclitaxel in relapsed high risk anthracycline treated breast cancer patients
M Elhabbash, AA Alwindi - Saudi medical journal, 2005 - pubmed.ncbi.nlm.nih.gov
… 1 , Abukris A Alwindi …
[CITATION][C] Paclitaxel in relapsed high risk anthracycline treated breast cancer patients
EH Manal M, A Abukris A - 2005 - pesquisa.bvsalud.org
Paclitaxel in relapsed high risk anthracycline treated breast cancer patients | Saudi Medical
Journal. 2005; 26 (9): 1471-1473 | IMEMR loading Conteúdo principal 1 Busca 2 Rodapé 3 +A …
Journal. 2005; 26 (9): 1471-1473 | IMEMR loading Conteúdo principal 1 Busca 2 Rodapé 3 +A …
[PDF][PDF] Failure to wean due to steroid psychosis
FY Khan - Saudi medical journal, 2005 - Citeseer
Fahmi Y. Khan, MD. ince their introduction as therapeutic agents, corticosteroids have been
associated with psychiatric symptoms ranging from mood disturbances to (florid) psychosis. …
associated with psychiatric symptoms ranging from mood disturbances to (florid) psychosis. …
Prognosis of male breast cancer: a systematic review of the literature.
P Bender, A Bergmann, CR Costa, LCS Thuler - 2014 - cabidigitallibrary.org
Objective: to discuss disease-free survival, overall survival, cancer specific survival, mortality
and potential complications of the surgical treatment of breast cancer in men. Methods: a …
and potential complications of the surgical treatment of breast cancer in men. Methods: a …
